Martina  Mueller  to  Clinical Trials, Phase III as Topic
                            
                            
                                This is a "connection" page, showing publications  Martina  Mueller  has written about  Clinical Trials, Phase III as Topic.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.044
         
        
        
     
 
    
        
        - 
            Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk factor: Protocol of a RCT. J Stroke Cerebrovasc Dis. 2021 Aug; 30(8):105815.
            
            
                Score: 0.044